Bispecific format suitable for use in high-through-put screening
The present disclosure relates to a novel bispecific protein complex and a method of using the complexes to screen for synergistic or novel biological function. The bispecific format is particularly suitable for high-throughput screening because all of its components can be expressed from cells as individual units and the units can be assembled simply by mixing without employing conjugation or coupling chemistry.
1. A bispecific protein complex having the formula A-X:Y-B wherein:
A-X is a first fusion protein;
Y-B is a second fusion protein;
: is a binding interaction between X and Y to form a bispecific protein complex between the first and second fusion proteins:
A is a first protein component of the bispecific protein complex selected from a Fab or Fab′ fragment;
B is a second protein component of the bispecific protein complex selected from a Fab or Fab′ fragment;
X is a first binding partner of a binding pair independently selected from an antigen or an antibody or binding fragment thereof,
wherein when X is an antigen, Y is an antibody or binding fragment thereof specific to the antigen represented by X; and
Y is a second binding partner of the binding pair independently selected from an antigen or an antibody or a binding fragment thereof,
wherein when Y is an antigen, X is an antibody or binding fragment thereof specific to the antigen represented by Y;
wherein A and B bind to two different epitopes on an antigen, or bind two different antigens, and wherein X or Y is a scFv specific to the peptide GCN4 having SEQ ID NO:1 or amino acids 1 to 38 of SEQ ID NO:1 and wherein the scFv is 525R4 having SEQ ID NO:3 or amino adds 1 to 243 of SEQ ID NO:3; or wherein X or Y is a peptide GCN4 having SEQ ID NO:1 or amino acids 1 to 38 of SEQ ID NO: 1.
2. The bispecific protein complex according to claim 1 , wherein A is a Fab fragment.
3. The bispecific protein complex according to claim 1 , wherein B is a Fab fragment.
4. The bispecific protein complex according to claim 1 , wherein X is fused, optionally via a linker, to the C-terminal of the heavy chain in the Fab or Fab′ fragment.
5. The bispecific protein complex according to claim 1 , wherein Y is fused, optionally via a linker, to the C-terminal of the heavy chain in the Fab or Fab′ fragment.
6. The bispecific protein complex according to claim 1 , wherein A and/or B is specific for an antigen selected from the group consisting of cell surface receptors, co-stimulatory molecules, checkpoint inhibitors, natural killer cell receptors, Immunoglobulin receptors, TNFR family receptors, B7 family receptors, adhesion molecules, integrins, cytokine/chemokine receptors, GPCRs, growth factor receptors, kinase receptors, tissue-specific antigens, cancer antigens, pathogen recognition receptors, complement receptors, hormone receptors, soluble molecules, cytokines, chemokines, leukotrienes, growth factors, hormones, enzymes, and ion channels.
7. The bispecific protein complex of claim 1 , wherein the bispecific protein complex is a biparatopic.
8. The bispecific protein complex of claim 1 , wherein the bispecific protein complex binds two different antigens.
9. A composition comprising one or more bispecific protein complexes defined in claim 1 .